Riddhi Siddhi Gluco Biols Limited (BOM:524480)
India · Delayed Price · Currency is INR 504.25
-23.65 (-4.48%)
At close: Feb 12, 2026
Riddhi Siddhi Gluco Biols Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 2,548 | 1,355 | 2,680 | 1,729 | 2,233 | 4,977 | |
Revenue Growth (YoY) | 61.09% | -49.43% | 54.96% | -22.55% | -55.13% | -13.65% |
Cost of Revenue | 2,284 | 1,047 | 2,313 | 1,446 | 1,771 | 3,993 |
Gross Profit | 264.26 | 308.3 | 366.98 | 283.66 | 461.6 | 983.98 |
Selling, General & Admin | 110.51 | 112.76 | 103.6 | 91.09 | 63.24 | 234.2 |
Other Operating Expenses | 175.52 | 120.62 | 191.31 | 184.26 | 128.68 | 861.77 |
Operating Expenses | 369.35 | 318.61 | 402.39 | 392.71 | 319.43 | 1,471 |
Operating Income | -105.09 | -10.31 | -35.41 | -109.05 | 142.17 | -486.78 |
Interest Expense | -154.68 | -96.06 | -88.42 | -75.63 | -74.45 | -255.94 |
Interest & Investment Income | 808.7 | 808.7 | 718.14 | 664.26 | 568.41 | 466.46 |
Currency Exchange Gain (Loss) | 1.06 | 1.06 | - | -1.45 | -0.92 | 20.54 |
Other Non Operating Income (Expenses) | -40.34 | -0.04 | 7.12 | 0.03 | -0.74 | 12.97 |
EBT Excluding Unusual Items | 509.65 | 703.36 | 601.43 | 478.16 | 634.48 | -242.75 |
Gain (Loss) on Sale of Investments | 17.48 | 17.48 | 70.89 | 6.21 | 22.61 | 47.61 |
Gain (Loss) on Sale of Assets | -6 | -6 | -6.85 | - | -14.42 | 14.24 |
Asset Writedown | - | - | -18.41 | - | - | - |
Other Unusual Items | - | - | - | - | - | 0.02 |
Pretax Income | 521.13 | 714.84 | 647.06 | 484.38 | 642.67 | -180.89 |
Income Tax Expense | 241.3 | 84.32 | 75.19 | 150.5 | 155.51 | 437.21 |
Earnings From Continuing Operations | 279.83 | 630.52 | 571.87 | 333.88 | 487.16 | -618.1 |
Minority Interest in Earnings | -11.85 | -16.12 | -5.28 | -4.85 | 3.72 | 150.26 |
Net Income | 809.06 | 614.4 | 566.6 | 329.03 | 490.87 | -467.84 |
Net Income to Common | 809.06 | 614.4 | 566.6 | 329.03 | 490.87 | -467.84 |
Net Income Growth | 134.60% | 8.44% | 72.20% | -32.97% | - | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Change (YoY) | 9.80% | - | - | - | - | - |
EPS (Basic) | 109.80 | 86.17 | 79.47 | 46.15 | 68.85 | -65.62 |
EPS (Diluted) | 109.80 | 86.17 | 79.47 | 46.15 | 68.85 | -65.62 |
EPS Growth | 113.65% | 8.44% | 72.20% | -32.97% | - | - |
Free Cash Flow | - | -769.75 | -44.51 | 2.41 | 1,554 | 1,228 |
Free Cash Flow Per Share | - | -107.96 | -6.24 | 0.34 | 217.96 | 172.25 |
Dividend Per Share | - | 3.000 | 3.000 | 1.500 | 1.000 | - |
Dividend Growth | - | - | 100.00% | 50.00% | - | - |
Gross Margin | 10.37% | 22.75% | 13.69% | 16.40% | 20.67% | 19.77% |
Operating Margin | -4.12% | -0.76% | -1.32% | -6.31% | 6.37% | -9.78% |
Profit Margin | 31.75% | 45.34% | 21.14% | 19.03% | 21.98% | -9.40% |
Free Cash Flow Margin | - | -56.80% | -1.66% | 0.14% | 69.59% | 24.68% |
EBITDA | -43.3 | 68.14 | 65.24 | 186.09 | 504.08 | -119.81 |
EBITDA Margin | -1.70% | 5.03% | 2.44% | 10.76% | 22.57% | -2.41% |
D&A For EBITDA | 61.8 | 78.45 | 100.65 | 295.13 | 361.91 | 366.97 |
EBIT | -105.09 | -10.31 | -35.41 | -109.05 | 142.17 | -486.78 |
EBIT Margin | -4.12% | -0.76% | -1.32% | -6.31% | 6.37% | -9.78% |
Effective Tax Rate | 46.30% | 11.80% | 11.62% | 31.07% | 24.20% | - |
Revenue as Reported | 3,386 | 2,233 | 3,489 | 2,400 | 2,848 | 5,566 |
Advertising Expenses | - | 0.29 | 0.09 | 0.17 | 0.04 | 0.28 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.